推官网,引流量

直推官网引流,大量子站导流 效果持久显著

批量建站,提收录

形成站群推广模式 让搜索引擎大量收录!

提权重,树权威

实现权重提升 树立行业权威

部署快,自主可控

免费下载

省成本,提效率

多分站齐推广,性价比高 批量数据分析,帮助及时调整优化

关于OD
关于OD
北京时刻5月20日凌晨1点,2026年谷歌I/O大会矜重演出,AI依旧是弥散的主
关于OD
【【【序论:iQOO的数字系列旗舰,迎来了新成员】】】 无人不晓,在iQOO的旗
关于OD
本翰墨数:1294,阅读时长简短2分钟 作家|第一财经何涛 封图|“耿同学讲故事
5月15日,英伟达CEO黄仁勋现身北京南锣饱读巷吃炸酱面,高清镜头捕捉到其指甲灰
第057期历史同时号码 OD体育app官网[扫码下载app,中过数字彩1千万以上
双色球2026056期开奖,本期奖号:红球10、19、21、22、31、33,蓝

OD资讯

ODZIXUN

OD资讯

查看更多
  • OD体育

    OD体育

  • 关于OD

    关于OD

  • OD资讯

    OD资讯

  • OD盘口

    OD盘口

OD盘口

  • OD盘口

OD体育(ODSports)官网入口

  • 012026-05

    OD体育app 深圳茶颜悦色开业,“黄牛”代购100元一杯

    4月22日,新茶饮品牌茶颜悦色在深圳的两家新店同期开业,迷惑了多半破钞者前来购买。由于破钞者温雅颇高,也迷惑了一些“黄牛”涨价代购。有“黄牛”示意,不错进行代购,但 价钱为两杯200元,要是不指定产物...
  • 012026-05

    OD体育 为什么倾吐完如故疾苦?疗愈师培训:一又友给不了你着

    有困扰的时分,好多东说念主王人会有这么的疑问:我干嘛要用钱找商榷师?跟身边的一又友聊聊,不是一样吗?雷同是倾吐,雷同是聊天,分裂到底在哪? 一又友的倾听,和你思象的不一样 一又友是维妙维肖的东说念主,...
  • 302026-04

    OD体育app 苏轼进寺庙呼吁一声秃驴安在,小头陀回了4个字

    苏轼,宋代的体裁行家,才华横溢,世称笔补造化,他不仅在诗词著作上有着超卓确实立,且擅长多种边界,号托病苦的全才。与他交情深厚的佛印,是他的相知兼知友,两东谈主非论在体裁创作上,依然在梵学究诘上,雷同切...
  • 302026-04

    OD体育app “单程票价超6000元”!国际机票暴涨,航班

    行将前去欧洲旅游的北京游客高女士,未猜测行程会被寰宇另一头的中东战火搅乱。从被动摈弃传统中转要津,到机票价钱暴涨一倍,再到担忧导弹飞越相关领空的传奇——好意思以伊战事激勉的全球动力颠簸,早已冲突了地缘...
临床医学名词词典
首页 > 按专业查询名词 > 查询PubMed相关文献
名词信息
Pubmed相关的文献
chronic lymphoproliferative disorder of NK cell相关文献:
Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
PMID:
A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.
PMID:
Adult patient with Epstein-Barr virus (EBV)-associated lymphoproliferative disorder: chronic active EBV infection or de novo extranodal natural killer (NK)/T-cell lymphoma, nasal type?
PMID:
New concepts in EBV-associated B, T, and NK cell lymphoproliferative disorders.
Quintanilla-Martinez L, Swerdlow SH, Tousseyn T, Barrionuevo C, Nakamura S, Jaffe ES.
Virchows Arch. 2023 Jan;482(1):227-244. doi: 10.1007/s00428-022-03414-4. Epub 2022 Oct 11.
PMID:36216980
A modern view of LGL leukemia.
Marchand T, Lamy T, Loughran TP Jr.
Blood. 2024 Oct 31;144(18):1910-1923. doi: 10.1182/blood.2023021790.
PMID:38848524
Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors.
Liu E, Marin D, Banerjee P, Macapinlac HA, Thompson P, Basar R, Nassif Kerbauy L, Overman B, Thall P, Kaplan M, Nandivada V, Kaur I, Nunez Cortes A, Cao K, Daher M, Hosing C, Cohen EN, Kebriaei P, Mehta R, Neelapu S, Nieto Y, Wang M, Wierda W, Keating M, Champlin R, Shpall EJ, Rezvani K.
N Engl J Med. 2020 Feb 6;382(6):545-553. doi: 10.1056/NEJMoa1910607.
PMID:32023374
Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
El-Mallawany NK, Curry CV, Allen CE.
Br J Haematol. 2022 Jan;196(1):31-44. doi: 10.1111/bjh.17638. Epub 2021 Jun 24.
PMID:34169507
Engineering of potent CAR NK cells using non-viral Sleeping Beauty transposition from minimalistic DNA vectors.
Bexte T, Botezatu L, Miskey C, Gierschek F, Moter A, Wendel P, Reindl LM, Campe J, Villena-Ossa JF, Gebel V, Stein K, Cathomen T, Cremer A, Wels WS, Hudecek M, Ivics Z, Ullrich E.
Mol Ther. 2024 Jul 3;32(7):2357-2372. doi: 10.1016/j.ymthe.2024.05.022. Epub 2024 May 14.
PMID:38751112
Chronic lymphoproliferative disorder of NK cells with TNFAIP3 and DNMT3A mutations.
Bulterys PL, Silva O.
Blood. 2021 Jun 17;137(24):3460. doi: 10.1182/blood.2021011812.
PMID:34137843
Chronic active Epstein-Barr virus disease: molecular pathogenesis, evolving concepts, and emerging therapies.
Kimura H, Cohen JI.
Blood. 2026 Apr 2;147(14):1562-1573. doi: 10.1182/blood.2025032277.
PMID:41490284
Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
Kurt H, Jorgensen JL, Amin HM, Patel KP, Wang SA, Lin P, Kanagal-Shamanna R, Loghavi S, Thakral B, Khogeer HA, Jabbour EJ, Li S, Yin CC, Medeiros LJ, Khoury JD.
Eur J Haematol. 2018 May;100(5):444-454. doi: 10.1111/ejh.13038. Epub 2018 Mar 9.
PMID:29385279
Clinical features and prognosis of chronic natural killer cell lymphoproliferative disorders.
Liu DL, Wang YJ, Qian SY, Ma SS, Ding MJ, Dong M, Zhang JM, Zhang MZ, Chen QJ, Zhang XD.
Hematology. 2024 Dec;29(1):2307817. doi: 10.1080/16078454.2024.2307817. Epub 2024 Feb 6.
PMID:38319083
NK cell recognition of hematopoietic cells by SLAM-SAP families.
Chen S, Dong Z.
Cell Mol Immunol. 2019 May;16(5):452-459. doi: 10.1038/s41423-019-0222-4. Epub 2019 Mar 25.
PMID:30911116
© Copyright 2021 鸿泰茂源  版权所有All Rights Reserved京ICP备11040441号-3